Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Filippo de Marinis"'
Autor:
Chiara Catania, Saverio Minucci, Emilio Bria, Charles Swanton, Filippo de Marinis, Tommaso De Pas, Aron Goldhirsch, Giampaolo Tortora, Laura Pala, Fabio Conforti, Giuseppe Giaccone, Richard D. Gelber, Paolo Veronesi, Rachel Rosenthal, E. Nicolò, Gianmarco Orsolini, Hadine Joffe, Giuseppe Viale, Paola Queirolo, Paola Zagami, Maristella Saponara, Vincenzo Bagnardi, Alberto Mantovani, Emilia Cocorocchio, Jennifer A. Wargo, Eleonora Pagan, Pier Francesco Ferrucci, Elisabetta Pennacchioli
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research
Purpose: We previously demonstrated that sex influences response to immune checkpoint inhibitors. In this article, we investigate sex-based differences in the molecular mechanisms of anticancer immune response and immune evasion in patients with NSCL
Autor:
Lorenza, Landi, Rita, Chiari, Marcello, Tiseo, Federica, D'Incà, Claudio, Dazzi, Antonio, Chella, Angelo, Delmonte, Laura, Bonanno, Diana, Giannarelli, Diego Luigi, Cortinovis, Filippo, de Marinis, Gloria, Borra, Alessandro, Morabito, Cesare, Gridelli, Domenico, Galetta, Fausto, Barbieri, Francesco, Grossi, Enrica, Capelletto, Gabriele, Minuti, Francesca, Mazzoni, Claudio, Verusio, Emilio, Bria, Greta, Alì, Rossella, Bruno, Agnese, Proietti, Gabriella, Fontanini, Lucio, Crinò, Federico, Cappuzzo
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 25(24)
Patients with pretreated advanced NSCLC and evidence ofFrom December 2014 to March 2017, 505 patients were screened and a total of 52 patients (26 patients per cohort) were enrolled onto the study. At data cutoff of September 2017, in cohort A, objec
Autor:
Katherine Schultz, Gianluca Spitaleri, Filippo de Marinis, Benjamin Solomon, Beow Y. Yeap, Daniel Shao-Weng Tan, Alice T. Shaw, Tomasso De Pas, Chiara Lazzari, Luc Friboulet, Jeffrey A. Engelman, Justin F. Gainor, Aziah Ahmad
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 21(12)
Purpose: Anaplastic lymphoma kinase (ALK) rearrangements are important therapeutic targets in non–small cell lung cancer (NSCLC) that confer sensitivity to the ALK inhibitors crizotinib and ceritinib. To determine the outcome of sequential treatmen